about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
10.61
-0.01
(-0.09%)
196.1K
XNAS Volume
XNAS 21 Sep, 2026 1:09 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..